심장 박동 관리 기기 시장 : 제품별, 최종 사용자별 - 세계 예측(2025-2030년)

The Cardiac Rhythm Management Devices Market was valued at USD 22.57 billion in 2023, expected to reach USD 24.80 billion in 2024, and is projected to grow at a CAGR of 9.98%, to USD 43.94 billion by 2030.

The scope of the cardiac rhythm management (CRM) devices market encompasses devices designed to treat arrhythmias and manage heart rate. This includes pacemakers, defibrillators, and cardiac resynchronization therapy devices. They are crucial in reducing morbidity and mortality associated with cardiac disorders, enhancing the quality of life for patients with chronic heart conditions. The application scope extends primarily to hospitals and specialized cardiac clinics with an end-use range that includes both implantable and external devices utilized by healthcare professionals. Market growth is significantly influenced by the increasing prevalence of cardiovascular diseases, advancements in technology focusing on miniaturization and better battery life, and an aging global population. Opportunities are ripe in emerging markets where healthcare infrastructure is expanding, providing openings for companies to introduce innovative, cost-effective solutions. Moreover, IoT integration with CRM devices for real-time monitoring presents untapped potential for improved patient outcomes.

Despite growth potential, challenges such as high cost and stringent regulatory approvals may impede market expansion. Concerns over cybersecurity risks in connected devices and complications arising from device implants are also barriers. Limitations include regional disparities in healthcare access and the high cost of device and procedure, often unaffordable for patients in low-income regions. For sustained business growth, innovations should focus on improving device biocompatibility, enhancing battery longevity, and advancing remote monitoring capabilities. Additionally, exploring partnerships with tech firms for improved data analytics capabilities can present competitive advantages. The market is dynamic, with a mix of established players and new entrants, driving continuous R&D efforts. Companies should focus on developing comprehensive value propositions, including post-sale services and smart device solutions that integrate with broader healthcare systems. Leveraging these insights can guide strategic initiatives in fostering technological advancements and entering new markets.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cardiac Rhythm Management Devices Market

The Cardiac Rhythm Management Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing incidences of heart failures
  • Growing use of photoplethysmography technology in wearables for atrial fibrillation (AFib) detection
  • Rising investments and grants for research on CM & CRM devices
• Market Restraints
  • Product recalls associated with cardiac rhythm management devices
• Market Opportunities
  • Introduction of advanced cardiac rhythm management devices
  • Increasing expenditure on healthcare services
• Market Challenges
  • Dearth of skilled professionals with knowledge and expertise in electrocardiography and cardiac

Porter's Five Forces: A Strategic Tool for Navigating the Cardiac Rhythm Management Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cardiac Rhythm Management Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cardiac Rhythm Management Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cardiac Rhythm Management Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cardiac Rhythm Management Devices Market

A detailed market share analysis in the Cardiac Rhythm Management Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cardiac Rhythm Management Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cardiac Rhythm Management Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cardiac Rhythm Management Devices Market

A strategic analysis of the Cardiac Rhythm Management Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cardiac Rhythm Management Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ACS Diagnostics, Alivecor, Inc., Asahi Kasei Corporation, Bexen Cardio, Biotronik SE & Co. KG, Boston Scientific Corporation, BPL Medical Technologies Private Limited, Defibtech LLC by Nihon Kohden Corporation, General Electric Company, HeartSine Technologies, Ltd. by Stryker Corporation, Hill-Rom Holdings, Inc. by Baxter International, Inc., Koninklijke Philips N.V., Lepu Medical Technology (Beijing) Co.,Ltd., Medtronic PLC, MicroPort Scientific Corporation, Narang Medical Ltd., TZ Medical, Inc., and ZOLL Medical Corporation.

Market Segmentation & Coverage

This research report categorizes the Cardiac Rhythm Management Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Cardiac Resynchronization Therapy, Defibrillators, and Pacemakers. The Cardiac Resynchronization Therapy is further studied across CRT-Defibrillator and CRT-Pacemakers. The Defibrillators is further studied across External Defibrillator and Implantable Cardioverter Defibrillators. The External Defibrillator is further studied across Automatic External Defibrillator, Manual External Defibrillator, and Wearable Cardioverter Defibrillator. The Implantable Cardioverter Defibrillators is further studied across S-ICD and T-ICD. The Pacemakers is further studied across External and Implantable.
• Based on End-User, market is studied across Ambulatory Surgery Centers and Hospitals, Clinics, & Cardiac Centers.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing incidences of heart failures
    • 5.1.1.2. Growing use of photoplethysmography technology in wearables for atrial fibrillation (AFib) detection
    • 5.1.1.3. Rising investments and grants for research on CM & CRM devices
  • 5.1.2. Restraints
    • 5.1.2.1. Product recalls associated with cardiac rhythm management devices
  • 5.1.3. Opportunities
    • 5.1.3.1. Introduction of advanced cardiac rhythm management devices
    • 5.1.3.2. Increasing expenditure on healthcare services
  • 5.1.4. Challenges
    • 5.1.4.1. Dearth of skilled professionals with knowledge and expertise in electrocardiography and cardiac
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Cardiac Rhythm Management Devices Market, by Product

• 6.1. Introduction
• 6.2. Cardiac Resynchronization Therapy
  • 6.2.1. CRT-Defibrillator
  • 6.2.2. CRT-Pacemakers
• 6.3. Defibrillators
  • 6.3.1. External Defibrillator
    • 6.3.1.1. Automatic External Defibrillator
    • 6.3.1.2. Manual External Defibrillator
    • 6.3.1.3. Wearable Cardioverter Defibrillator
  • 6.3.2. Implantable Cardioverter Defibrillators
    • 6.3.2.1. S-ICD
    • 6.3.2.2. T-ICD
• 6.4. Pacemakers
  • 6.4.1. External
  • 6.4.2. Implantable

7. Cardiac Rhythm Management Devices Market, by End-User

• 7.1. Introduction
• 7.2. Ambulatory Surgery Centers
• 7.3. Hospitals, Clinics, & Cardiac Centers

8. Americas Cardiac Rhythm Management Devices Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Cardiac Rhythm Management Devices Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Cardiac Rhythm Management Devices Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. ACS Diagnostics
• 3. Alivecor, Inc.
• 4. Asahi Kasei Corporation
• 5. Bexen Cardio
• 6. Biotronik SE & Co. KG
• 7. Boston Scientific Corporation
• 8. BPL Medical Technologies Private Limited
• 9. Defibtech LLC by Nihon Kohden Corporation
• 10. General Electric Company
• 11. HeartSine Technologies, Ltd. by Stryker Corporation
• 12. Hill-Rom Holdings, Inc. by Baxter International, Inc.
• 13. Koninklijke Philips N.V.
• 14. Lepu Medical Technology (Beijing) Co.,Ltd.
• 15. Medtronic PLC
• 16. MicroPort Scientific Corporation
• 17. Narang Medical Ltd.
• 18. TZ Medical, Inc.
• 19. ZOLL Medical Corporation